# Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer win

> **Open Intelligence Dossier** · First detected: 2026-10-19 22:40 UTC · Category: Business

## Executive Summary
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer win" is generating significant coverage in the Business category, with 4 articles from 4 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Morningstar, Yahoo Finance, Merck Group and FirstWord Pharma. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Morningstar | Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders? | [Source Link](https://news.google.com/rss/articles/CBMixAFBVV95cUxObTlhUC1HaWI0UVFxMUJDSHFNUFk1U01TTHpZV19ERjVGY2czRjQ5LXlSay0zMkF4TVlYaEI4bXpNcHFYSkdFdXl1b1BNSlEyeXo5VkRWNFZLUXFzd0Z1WENCNW9KdS1yUjZqTTdudzlmeVBwUHFhcVJQZUxEa0tHSVJYZUkzNzBFX2tsXzRQTHFfSVlxWXlxLWhfdFRTSWlQaEwxYnVsZ2w2SnBXNEhNM19RempRb2dWbThXTzZjRHQzQWN3?oc=5) |
| Yahoo Finance | A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxPUjNNUS0xZEJRUThXRjZaeFVLMVNpZFpJaXZwbWFVQkNsa2U0cG5mQjlUNV80UkZsb1VVc2VBYnAzU2ZaZkM4MHV5NVFiOU96djZDOTJoM0ZkOTJuZnpjcVdfWkQ0clNqeG1fV2lIRUhYN0kyMHNXQkRTMERIYTN3dndrSEpuc0NhTU9RcFhR?oc=5) |
| Merck Group | Acquisition of Silence Therapeutics to Strengthen Rare Disease Pipeline | [Source Link](https://news.google.com/rss/articles/CBMie0FVX3lxTE1hempRQkRPUHpFWWZiOUxhV3JldGlHQlpLRnlOc2pKXzJGT2xveWxnajkxMTN6LTNtWGVsa0lXbXhQY0x0aDkyaDQ4ZXJNSlFWZlBnbFU5eHBXVFVLeHc5Sk4wU3VVRUhsa0kzUXpVeFFOWDRVamlmaE4zNA?oc=5) |
| FirstWord Pharma | Merck KGaA doubles down on rare disease buildout with $1.3B Silence buy | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE1RY1VhWTJrb2ZXTXdEbTFqZFp2eXNac1NKSVh6S0RoZmtMaWNGczZjczNLYlFDT2dFN0tvSG5FZF9ZeVZjMlZZTWFsTW5NX2ZDLWV3?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-19/merck-kgaa-buys-silence-in-1-3b-deal-after-sirna-drug-s-phase-2-blood-cancer-win*